Japan Radiodermatitis Market Size & Outlook, 2025-2030
Related Markets
Japan radiodermatitis market highlights
- The Japan radiodermatitis market generated a revenue of USD 16.6 million in 2024 and is expected to reach USD 21.7 million by 2030.
- The Japan market is expected to grow at a CAGR of 4.5% from 2025 to 2030.
- In terms of segment, topical was the largest revenue generating product in 2024.
- Topical is the most lucrative product segment registering the fastest growth during the forecast period.
Radiodermatitis market data book summary
| Market revenue in 2024 | USD 16.6 million |
| Market revenue in 2030 | USD 21.7 million |
| Growth rate | 4.5% (CAGR from 2025 to 2030) |
| Largest segment | Topical |
| Fastest growing segment | Topical |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Topical, Dressings |
| Key market players worldwide | Smith & Nephew PLC, Integra LifeSciences, ConvaTec Group PLC, 3M Co, Molnlycke Health Care, Alliqua BioMedical, Stratpharma, BMG Pharma |
Other key industry trends
- In terms of revenue, Japan accounted for 3.8% of the global radiodermatitis market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China radiodermatitis market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 26.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiodermatitis Market Scope
Radiodermatitis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| BMG Pharma | View profile | 11-50 | Milan, Lombardia, Italy, Europe | https://www.bmgpharma.com |
| Stratpharma | View profile | 101-250 | Basel, Basel-Stadt, Switzerland, Europe | http://stratpharma.com/ |
| Alliqua BioMedical | View profile | 11-50 | Yardley, Pennsylvania, United States, North America | http://alliqua.com/ |
| Molnlycke Health Care | View profile | 5001-10000 | Gothenburg, Vastra Gotaland, Sweden, Europe | http://www.molnlycke.com/ |
| Integra LifeSciences | View profile | 5001-10000 | Princeton, New Jersey, United States, North America | http://www.integralife.com |
| ConvaTec Group PLC | View profile | 10136 | 20 Eastbourne Terrace, 7th Floor, Paddington, London, United Kingdom, W2 6LG | https://www.convatecgroup.com |
| Smith & Nephew PLC | View profile | 18452 | Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, United Kingdom, WD18 8YE | https://www.smith-nephew.com |
| 3M Co | View profile | 85000 | 3M Center, St. Paul, MN, United States, 55144 | https://www.3m.com |
Japan radiodermatitis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiodermatitis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 71.69% in 2024. Horizon Databook has segmented the Japan radiodermatitis market based on topical, dressings covering the revenue growth of each sub-segment from 2018 to 2030.
The radiodermatitis market in Japan is expected to grow over the forecast period owing to the presence of factors such as increasing prevalence of radiation burn injuries and economic development.
Moreover, favorable healthcare policies and presence of government organizations such as Japanese Society for Radiation burn Injuries (JSBI) aid in driving the market growth.
Higher awareness levels and high demand of better products are the factors boosting market growth in this region. Availability of advanced technology and ability to develop new products are the factors expected to continue the high growth rate of the market.
Reasons to subscribe to Japan radiodermatitis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan radiodermatitis market databook
-
Our clientele includes a mix of radiodermatitis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan radiodermatitis market , including forecasts for subscribers. This country databook contains high-level insights into Japan radiodermatitis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan Product - Radiodermatitis Market size, 2024 - 2030 (US$M)
Japan Radiodermatitis Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
